Published in JAMA on October 11, 2000
Impact of C-reactive protein on in-stent restenosis: a meta-analysis. Tex Heart Inst J (2010) 0.92
Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry. Clin Res Cardiol (2007) 0.85
Influence of age, sex, and aerobic capacity on forearm and skin blood flow and vascular conductance. Eur J Appl Physiol (2010) 0.82
A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients. Indian Heart J (2012) 0.81
A novel mouse model of in-stent restenosis. Atherosclerosis (2009) 0.81
The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years? Korean Circ J (2013) 0.80
Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management. Z Kardiol (2005) 0.79
Electrografting of a biodegradable layer as a primer adhesion coating onto a metallic stent: in vitro and in vivo evaluations. J Mater Sci Mater Med (2013) 0.78
Debate: PCI vs CABG: a moving target, but we are gaining. Curr Control Trials Cardiovasc Med (2001) 0.78
Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry. Heart Vessels (2011) 0.77
Plasma polymerized n-butyl methacrylate coating with potential for re-endothelialization of intravascular stent devices. J Mater Sci Mater Med (2007) 0.77
Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry. J Clin Diagn Res (2013) 0.75
Stent scrutiny. JAMA (2000) 0.75
New stent design for use in small coronary arteries during percutaneous coronary intervention. Med Devices (Auckl) (2010) 0.75
Granulation encapsulated stent: a new therapeutic approach for vascular implantation. Heart (2006) 0.75
Three cases of non-surgical treatment of stent loss during percutaneous coronary intervention. Korean Circ J (2010) 0.75
Clinical Outcomes from Unselected "Real-World" Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent. Scientifica (Cairo) (2015) 0.75
An experimental study of electrochemical polishing for micro-electro-discharge-machined stainless-steel stents. J Mater Sci Mater Med (2011) 0.75
Nitinol Carbofilm coated stents for peripheral applications: study in the porcine model. J Mater Sci Mater Med (2005) 0.75
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation (2000) 5.53
Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med (1993) 4.56
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost (2009) 4.30
Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. J Am Coll Cardiol (1989) 3.95
Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol (1992) 3.94
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation (1997) 3.52
The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. N Engl J Med (1996) 2.68
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med (2001) 2.54
Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52
Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42
Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation (1997) 2.41
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol (1998) 2.12
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clin Proc (1993) 2.06
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99
The alluring myth of private medicine. CMAJ (1996) 1.98
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95
Permanent pacemaker infections: characterization and management. Am J Cardiol (1981) 1.95
Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol (1999) 1.92
Management of balloon rupture during rigid stent deployment. Cathet Cardiovasc Diagn (1995) 1.91
Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart (2009) 1.89
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol (1992) 1.79
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76
Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72
Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J (2001) 1.72
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest (1998) 1.68
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg (1996) 1.66
Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation (1990) 1.65
Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.65
Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol (1996) 1.65
The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med (1998) 1.60
Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation (1996) 1.59
Comorbid conditions and outcomes after percutaneous coronary intervention. Heart (2007) 1.57
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Circulation (1995) 1.56
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med (1983) 1.56
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation (1995) 1.55
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation (2001) 1.54
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. J Am Coll Cardiol (2000) 1.53
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc (1998) 1.53
Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol (1990) 1.52
Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups. Mayo Clin Proc (1994) 1.52
Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation (1985) 1.51
Neointimal thickening after severe coronary artery injury is limited by a short-term administration of a factor Xa inhibitor. Results in a porcine model. Circulation (1996) 1.50
Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J (2000) 1.50
Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res (2001) 1.49
Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia. Cardiovasc Res (1999) 1.48
Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med (2000) 1.48
Natural history of candidates for balloon aortic valvuloplasty. Mayo Clin Proc (1987) 1.48
Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc (1992) 1.47
Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary artery occlusions. Circulation (1992) 1.47
Atrial "J" pacing lead retention wire fracture: radiographic assessment, incidence of fracture, and clinical management. Pacing Clin Electrophysiol (1995) 1.46
Extraction of the Telectronics Accufix 330-801 atrial lead: the Mayo Clinic experience. Mayo Clin Proc (1996) 1.45
Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation (2000) 1.45
Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. J Am Coll Cardiol (1998) 1.44
Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol (1996) 1.43
A new approach for dilation of bifurcation stenoses: the dual probe technique. Mayo Clin Proc (1989) 1.42
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42
Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester. Mayo Clin Proc (1996) 1.42
Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol (2001) 1.41
Predictors of smoking cessation after percutaneous coronary revascularization. Mayo Clin Proc (1998) 1.41
Decreasing mortality with primary percutaneous coronary intervention in patients with acute myocardial infarction: the Mayo Clinic experience from 1991 through 1997. Mayo Clin Proc (2000) 1.41
Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med (2000) 1.41
Efficacy of percutaneous mitral balloon valvuloplasty with the inoue balloon. Mayo Clin Proc (1991) 1.40
Technical considerations when intervening with coronary device catheters in the vicinity of previously deployed stents. Catheter Cardiovasc Interv (2001) 1.40
Transmyocardial and percutaneous myocardial revascularization: current and future role in the treatment of coronary artery disease. Mayo Clin Proc (1999) 1.40
Early outcome after placement of a metallic intracoronary stent: initial Mayo Clinic experience. Mayo Clin Proc (1991) 1.40
Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol (1995) 1.40
Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indications. Cathet Cardiovasc Diagn (1997) 1.39
Impact of stent size and indication for stent placement on immediate outcome. Cathet Cardiovasc Diagn (1996) 1.39
Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women. Mayo Clin Proc (1997) 1.39
Clinical, angiographic, and procedural correlates of abrupt vascular closure during coronary intervention: a 10-year experience at Mayo Clinic. Catheter Cardiovasc Interv (1999) 1.39